Can a smartphone app ease the stress of cancer genetic testing?
NCT ID NCT07387263
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a digital app called the Genetics Adviser for Mainstream Care (GA-Mainstream) that educates cancer patients about genetic testing and delivers their results. Researchers want to see if using the app reduces distress and improves the patient experience compared to standard care. The study will enroll 180 adults with breast, prostate, colon, ovarian, or pancreatic cancer who are already getting genetic testing through their oncologist.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Genetics Adviser for Mainstream Care (GA-Mainstream) digital application
What this could lead to
If successful, this could provide a standard, evidence-based digital tool to support cancer patients through genetic testing, reducing anxiety and improving coordination of care.
What could go wrong
This is a relatively small, early-stage study (180 participants) testing a behavioral intervention, not a drug. The app may not significantly reduce distress compared to standard care, and results may not apply to non-English speakers or those without internet access.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mount Sinai Hospital
RECRUITINGToronto, Ontario, M5G 1X5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sunnybrook Hospital
RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••